Poor Money Management May Be Early Indicator Of Alzheimer’s Disease, Say UAB Researchers
September 22, 2009
Adapted from the University of Alabama at Birmingham (UAB)
Inability to handle financial transactions or manage money may be an early indicator that a person with mild memory problems soon is likely to develop Alzheimer's disease, according to new research from the University of Alabama at Birmingham (UAB) Alzheimer's Disease Center, part of the Department of Neurology. The findings, published in the September 22, 2009 edition of Neurology, the medical journal of the American Academy of Neurology, examined patients with a condition known as mild cognitive impairment (MCI), thought to be a precursor to Alzheimer's.
The researchers followed 87 people with MCI and 76 controls with no memory problems. The participant's ability to manage certain financial skills was assessed at the beginning of the study and then again one year later, using a UAB-developed tool called the Financial Capacity Instrument (FCI). The skills included understanding a bank statement, balancing a checkbook, paying bills, preparing bills for mailing and counting coins and currency.
During the course of the year, 25 of the MCI patients had progressed to Alzheimer's disease. The overall FCI scores for those 25 participants decreased 6 percent from their original scores and 9 percent for checkbook-management skills. The control group and those MCI patients who did not progress to dementia maintained the level of their FCI scores throughout the year.
"Declining financial skills are detectable in patients with mild cognitive impairment in the year before their conversion to Alzheimer's disease," said Daniel Marson, Ph.D., JD, professor of neurology and director of the UAB Alzheimer's Disease Center. "This indicates that physicians and health-care providers need to watch patients with MCI closely for declining financial skills and advise families and caregivers to take steps to avoid negative financial events."
View all news updates for Alzheimer's disease
Disclaimer: The information provided in this section is a public service of the American Health Assistance Foundation, and should not in any way substitute for the advice of a qualified healthcare professional and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. The American Health Assistance Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.
